Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 80255 BALTIMORE, MD
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,413,744
-$2,863,756 QoQ
Shares Held
260,784
-5.1% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 256 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. TARS ranks #102 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in TARS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,413,744 260,784
2026-03-31 $19,277,500 274,804
2025-12-31 $42,477,706 518,780
2025-09-30 $26,913,290 452,857
2025-06-30 $15,551,869 383,902
2025-03-31 $22,251,993 433,171
2024-12-31 $25,513,000 460,773
2024-09-30 $7,871,070 239,315
2024-06-30 $7,916,853 291,275
2024-03-31 $12,638,276 347,683